Abstract
Infants, children, and adolescents with chronic kidney disease (CKD), end-stage renal disease (ESRD), and kidney disorders such as nephrotic syndrome face unique nutritional challenges. The goals of this chapter are to outline the nutritional problems associated with various forms of kidney disease and describe interventions to correct them. The approach to nutritional management varies greatly based on the age of the child and type of kidney disorder. The primary goals of nutrition in infants and young children with CKD are to promote adequate weight gain, linear growth, and hydration as well as maintain electrolyte homeostasis. For older children and teenagers with CKD and ESRD, the traditional nutritional goals have focused on the management of potassium and phosphorus, fluid balance, and growth. However, as our understanding of nutrition evolved, it is now recognized that diet (quantity and quality of food) has far-reaching effects on overall health. Nutrition is extremely important in modulating inflammation, immune function, and the gut microbiome, all of which play a major role in preventing chronic diseases including cardiovascular disease (CVD) and cancer. A large body of research over the past decade has led to a paradigm shift in nutrition and kidney disease. The recommendations for protein intake in the ESRD population as well as the most effective way to manage dietary phosphorus have changed dramatically. In addition, in some cases of idiopathic nephrotic syndrome, diet therapy has been effective as a treatment of the disease rather than simply managing symptoms. The following sections will identify nutritional problems in various kidney disorders and describe the diet therapy to best help manage them.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ingulli EG, Mak RH. Growth in children with chronic kidney disease: role of nutrition, growth hormone, dialysis, and steroids. Curr Opin Pediatr. 2014;26(2):187–92.
Graf L, et al. Nutrition assessment and hormonal influences on body composition in children with chronic kidney disease. Adv Chronic Kidney Dis. 2007;14(2):215–23.
Foster BJ, McCauley L, Mak RH. Nutrition in infants and very young children with chronic kidney disease. Pediatr Nephrol. 2012;27(9):1427–39.
Group KW. KDOQI clinical practice guideline for nutrition in children with CKD: 2008 update. Executive summary. Am J Kidney Dis. 2009;53(3 Suppl 2):S11–104.
Bunchman TE. Nutritional delivery in infants with CKD: techniques to avoid hyperkalemia. J Ren Nutr. 2013;23(5):387–8.
Thompson K, et al. Pretreatment of formula or expressed breast milk with sodium polystyrene sulfonate (Kayexalate((R))) as a treatment for hyperkalemia in infants with acute or chronic renal insufficiency. J Ren Nutr. 2013;23(5):333–9.
Kovacs CS. Bone development and mineral homeostasis in the fetus and neonate: roles of the calciotropic and phosphotropic hormones. Physiol Rev. 2014;94(4):1143–218.
Kovacs CS. Bone metabolism in the fetus and neonate. Pediatr Nephrol. 2014;29(5):793–803.
Abrams SA. Calcium and vitamin d requirements of enterally fed preterm infants. Pediatrics. 2013;131(5):e1676–83.
Hicks PD, et al. Total calcium absorption is similar from infant formulas with and without prebiotics and exceeds that in human milk-fed infants. BMC Pediatr. 2012;12:118.
Alon U, Chan JCM. Phosphate in pediatric health and disease. Boca Raton: CRC Press; 1993. p. 327.
Bailey DA, et al. Calcium accretion in girls and boys during puberty: a longitudinal analysis. J Bone Miner Res. 2000;15(11):2245–50.
Karlen J, Aperia A, Zetterstrom R. Renal excretion of calcium and phosphate in preterm and term infants. J Pediatr. 1985;106(5):814–9.
Aladangady N, et al. Urinary excretion of calcium and phosphate in preterm infants. Pediatr Nephrol. 2004;19(11):1225–31.
In: Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. Washington, DC: National Academy Press; 1997.
Gattineni J, Baum M. Developmental changes in renal tubular transport-an overview. Pediatr Nephrol. 2013.
Takaiwa M, et al. Fibroblast growth factor 23 concentrations in healthy term infants during the early postpartum period. Bone. 2010;47(2):256–62.
Raaijmakers R, et al. Pre-treatment of dairy and breast milk with sevelamer hydrochloride and sevelamer carbonate to reduce phosphate. Perit Dial Int. 2013;33(5):565–72.
Parekh RS, et al. Improved growth in young children with severe chronic renal insufficiency who use specified nutritional therapy. J Am Soc Nephrol. 2001;12(11):2418–26.
Ivanova E, et al. Cystinosis: clinical presentation, pathogenesis and treatment. Pediatr Endocrinol Rev. 2014;12 Suppl 1:176–84.
Nesterova G, et al. Cystinosis: renal glomerular and renal tubular function in relation to compliance with cystine-depleting therapy. Pediatr Nephrol. 2014.
Meyer KB, Levey AS. Controlling the epidemic of cardiovascular disease in chronic renal disease: report from the National Kidney Foundation Task Force on Cardiovascular Disease. J Am Soc Nephrol. 1998;9(12 Suppl):S31–42.
Foster BJ, et al. Change in mortality risk over time in young kidney transplant recipients. Am J Transplant. 2011;11(11):2432–42.
Mitsnefes MM. Cardiovascular disease in children with chronic kidney disease. J Am Soc Nephrol. 2012;23(4):578–85.
Flynn JT, et al. Blood pressure in children with chronic kidney disease: a report from the Chronic Kidney Disease in Children study. Hypertension. 2008;52(4):631–7.
Saland JM, et al. Dyslipidemia in children with chronic kidney disease. Kidney Int. 2010;78(11):1154–63.
Oh J, et al. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation. 2002;106(1):100–5.
Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32(5 Suppl 3):S112–9.
Shroff R, et al. HDL in children with CKD promotes endothelial dysfunction and an abnormal vascular phenotype. J Am Soc Nephrol. 2014;25(11):2658–68.
Evenepoel P, Meijers BK. Dietary fiber and protein: nutritional therapy in chronic kidney disease and beyond. Kidney Int. 2012;81(3):227–9.
Uribarri J, Oh MS. The key to halting progression of CKD might be in the produce market, not in the pharmacy. Kidney Int. 2012;81(1):7–9.
Cordain L, et al. Origins and evolution of the Western diet: health implications for the 21st century. Am J Clin Nutr. 2005;81(2):341–54.
Tuso PJ, et al. Nutritional update for physicians: plant-based diets. Perm J. 2013;17(2):61–6.
Krishnamurthy VM, et al. High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease. Kidney Int. 2012;81(3):300–6.
Ramezani A, Raj DS. The gut microbiome, kidney disease, and targeted interventions. J Am Soc Nephrol. 2014;25(4):657–70.
Brown K, et al. Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients. 2012;4(8):1095–119.
De Filippo C, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A. 2010;107(33):14691–6.
Vaziri ND, et al. Chronic kidney disease alters intestinal microbial flora. Kidney Int. 2013;83(2):308–15.
Niwa T. Indoxyl sulfate is a nephro-vascular toxin. J Ren Nutr. 2010;20(5 Suppl):S2–6.
Evenepoel P, et al. Uremic toxins originating from colonic microbial metabolism. Kidney Int Suppl. 2009;114:S12–9.
Vanholder R, et al. The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review. J Am Soc Nephrol. 2014;25(9):1897–907.
Moe SM, et al. Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease. Clin J Am Soc Nephrol. 2011;6(2):257–64.
Noori N, et al. Organic and inorganic dietary phosphorus and its management in chronic kidney disease. Iran J Kidney Dis. 2010;4(2):89–100.
Fukagawa M, Komaba H, Miyamoto K. Source matters: from phosphorus load to bioavailability. Clin J Am Soc Nephrol. 2011;6(2):239–40.
Kalantar-Zadeh K, et al. Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. Clin J Am Soc Nephrol. 2010;5(3):519–30.
Gutierrez OM, et al. Dietary patterns and risk of death and progression to ESRD in individuals with CKD: a cohort study. Am J Kidney Dis. 2014;64(2):204–13.
Dekker MJ, et al. Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome. Am J Physiol Endocrinol Metab. 2010;299(5):E685–94.
Carvalho CR, et al. Fructose alters adiponectin, haptoglobin and angiotensinogen gene expression in 3T3-L1 adipocytes. Nutr Res. 2010;30(9):644–9.
Johnson RJ, Sanchez-Lozada LG, Nakagawa T. The effect of fructose on renal biology and disease. J Am Soc Nephrol. 2010;21(12):2036–9.
Khitan Z, Kim DH. Fructose: a key factor in the development of metabolic syndrome and hypertension. J Nutr Metab. 2013;2013:682673.
Madero M, et al. Dietary fructose and hypertension. Curr Hypertens Rep. 2011;13(1):29–35.
DiNicolantonio JJ, O’Keefe JH, Lucan SC. An unsavory truth: sugar, more than salt, predisposes to hypertension and chronic disease. Am J Cardiol. 2014;114(7):1126–8.
Shroff R. Phosphate is a vascular toxin. Pediatr Nephrol. 2013;28(4):583–93.
Shuto E, et al. Dietary phosphorus acutely impairs endothelial function. J Am Soc Nephrol. 2009;20(7):1504–12.
Tonelli M, et al. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation. 2005;112(17):2627–33.
Chang AR, et al. High dietary phosphorus intake is associated with all-cause mortality: results from NHANES III. Am J Clin Nutr. 2014;99(2):320–7.
Sullivan CM, Leon JB, Sehgal AR. Phosphorus-containing food additives and the accuracy of nutrient databases: implications for renal patients. J Ren Nutr. 2007;17(5):350–4.
Uribarri J. Phosphorus additives in food and their effect in dialysis patients. Clin J Am Soc Nephrol. 2009;4(8):1290–2.
Sherman RA, Mehta O. Phosphorus and potassium content of enhanced meat and poultry products: implications for patients who receive dialysis. Clin J Am Soc Nephrol. 2009;4(8):1370–3.
Azocar MA, et al. Body composition in children on peritoneal dialysis. Adv Perit Dial. 2004;20:231–6.
Quan A, Baum M. Protein losses in children on continuous cycler peritoneal dialysis. Pediatr Nephrol. 1996;10(6):728–31.
Uribarri J. The obsession with high dietary protein intake in ESRD patients on dialysis: is it justified? Nephron. 2000;86(2):105–8.
Wolfson M, Jones MR, Kopple JD. Amino acid losses during hemodialysis with infusion of amino acids and glucose. Kidney Int. 1982;21(3):500–6.
Chazot C, et al. Dialytic nutrition: provision of amino acids in dialysate during hemodialysis. Kidney Int. 1997;52(6):1663–70.
Ikizler TA, et al. Amino acid and albumin losses during hemodialysis. Kidney Int. 1994;46(3):830–7.
Canepa A, et al. Long-term effect of amino-acid dialysis solution in children on continuous ambulatory peritoneal dialysis. Pediatr Nephrol. 1991;5(2):215–9.
Canepa A, et al. Continuous ambulatory peritoneal dialysis (CAPD) of children with amino acid solutions: technical and metabolic aspects. Perit Dial Int. 1990;10(3):215–20.
Hanning RM, Balfe JW, Zlotkin SH. Effectiveness and nutritional consequences of amino acid-based vs glucose-based dialysis solutions in infants and children receiving CAPD. Am J Clin Nutr. 1987;46(1):22–30.
Qamar IU, et al. Effects of 3-month amino acid dialysis compared to dextrose dialysis in children on continuous ambulatory peritoneal dialysis. Perit Dial Int. 1994;14(1):34–41.
Qamar IU, et al. Effects of amino acid dialysis compared to dextrose dialysis in children on continuous cycling peritoneal dialysis. Perit Dial Int. 1999;19(3):237–47.
Goraya N, et al. A comparison of treating metabolic acidosis in CKD stage 4 hypertensive kidney disease with fruits and vegetables or sodium bicarbonate. Clin J Am Soc Nephrol. 2013;8(3):371–81.
Goraya N, et al. Dietary acid reduction with fruits and vegetables or bicarbonate attenuates kidney injury in patients with a moderately reduced glomerular filtration rate due to hypertensive nephropathy. Kidney Int. 2012;81(1):86–93.
Nevin KG, Rajamohan T. Beneficial effects of virgin coconut oil on lipid parameters and in vitro LDL oxidation. Clin Biochem. 2004;37(9):830–5.
Noori N, et al. Dietary omega-3 fatty acid, ratio of omega-6 to omega-3 intake, inflammation, and survival in long-term hemodialysis patients. Am J Kidney Dis. 2011;58(2):248–56.
Uy N, et al. Effects of gluten-free, dairy-free diet on childhood nephrotic syndrome and gut microbiota. Pediatr Res. 2014;77:252.
Sandberg DH, et al. Severe steroid-responsive nephrosis associated with hypersensitivity. Lancet. 1977;1(8008):388–91.
Laurent J, Lagrue G. Dietary manipulation for idiopathic nephrotic syndrome. A new approach to therapy. Allergy. 1989;44(8):599–603.
Sieniawska M, et al. The role of cow’s milk protein intolerance in steroid-resistant nephrotic syndrome. Acta Paediatr. 1992;81(12):1007–12.
de Sousa JS, et al. Cow’s milk protein sensitivity: a possible cause of nephrotic syndrome in early infancy. J Pediatr Gastroenterol Nutr. 1995;21(2):235–7.
Rasoulpour M, Dalidowitz C. 170: resolution of steroid-dependency by a dairy/hypoallergenic diet in children with nephrotic syndrome. Am J Kidney Dis. 2007;49(4):B67.
Skripak JM, et al. The natural history of IgE-mediated cow’s milk allergy. J Allergy Clin Immunol. 2007;120(5):1172–7.
Wood RA. The natural history of food allergy. Pediatrics. 2003;111(6 Pt 3):1631–7.
Mansueto P, et al. Non-celiac gluten sensitivity: literature review. J Am Coll Nutr. 2014;33(1):39–54.
Kaskel F, et al. Improving CKD therapies and care: a national dialogue. Clin J Am Soc Nephrol. 2014;9(4):815–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer-Verlag Berlin Heidelberg (outside the USA)
About this entry
Cite this entry
Graf, L., Reidy, K., Kaskel, F.J. (2016). Nutrition Management in Childhood Kidney Disease: An Integrative and Lifecourse Approach. In: Avner, E., Harmon, W., Niaudet, P., Yoshikawa, N., Emma, F., Goldstein, S. (eds) Pediatric Nephrology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-43596-0_11
Download citation
DOI: https://doi.org/10.1007/978-3-662-43596-0_11
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-43595-3
Online ISBN: 978-3-662-43596-0
eBook Packages: MedicineReference Module Medicine